Form 4 for NUTX Nutex Health Inc.
Accepted 2022-04-05 00:00:00 ET · period of report 2022-04-01 · accession 0001062993-22-009699 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-04-05 | 2022-04-01 | NUTX | Chang Michael L. | Chief Medical Off | A - Grant | — | +12.01M | 12.01M | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-01 | A | A | 12,008,523 | — | 12,008,523 | I By Michael Chang PLLC | — | — | (F1) At the closing of the business combination pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on February 14, 2022, as supplemented, the reporting person received 3.571428575 shares of Common Stock of the Issuer in exchange for each membership interest in Nutex Health Holdco LLC. |